Neogenomics (NEO) Other Non Operating Income (2017 - 2026)
Neogenomics' (NEO) quarterly Other Non Operating Income came in at $11.2 million in Q2 2026, up 2219.71% YoY from $482000.0 in Q2 2025, and up 93275.0% on a QoQ basis from -$12000.0 in Q1 2026.
Neogenomics (NEO) Other Non Operating Income (2017 - 2026) Analysis & Trends
Neogenomics (NEO) has 10 years of Other Non Operating Income data on file, last reported at $11.2 million in Q2 2026.
- Quarterly Other Non Operating Income rose 2219.71% year-over-year to $11.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.9 million (up 2421.48% YoY) and the FY2025 annual result came in at $296000.0, up 178.1% from the prior year.
- Other Non Operating Income advanced to $11.2 million in Q2 2026, from -$12000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $11.2 million in Q2 2026 to a low of -$431000.0 in Q4 2024.
- A 5-year average of $639833.3 and a median of $12000.0 in 2022 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income slumped 484.0% — and 2025, when it soared 24200.0%.
- Tracing NEO's Other Non Operating Income over 5 years: stood at -$1000.0 in 2022, then soared by 12500.0% to $124000.0 in 2023, then plunged by 447.58% to -$431000.0 in 2024, then surged by 119.49% to $84000.0 in 2025, then soared by 13210.71% to $11.2 million in 2026.
- The last three Other Non Operating Income figures came in at $11.2 million (Q2 2026), -$12000.0 (Q1 2026), and $84000.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.18 Mn |
| Mar 31, 2026 | -12,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | -431,000.00 |
| Sep 30, 2024 | 317,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -263,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Sep 30, 2023 | -96,000.00 |
| Jun 30, 2023 | 730,000.00 |
| Mar 31, 2023 | -114,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | -405,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | -930,000.00 |
| Sep 30, 2021 | 89,000.00 |